Top Markets
#1 Akedo Akedo +61.65%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.50%
#4 Cross Cross +46.58%
#5 Black Phoenix Black Phoenix +34.22%
#6 Velvet Velvet +31.90%
#7 OVERTAKE OVERTAKE +27.47%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.31%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.54%
#10 Movement Movement +13.62%
Coin of the day
Akedo Akedo
Настройки
Язык
Pусский
Валюта
USD
Тема
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Ранг среди акций #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Цена акции
$0.02243487
Последняя синхронизация: 2025-06-04
Рыночная капитализация
$650.09K
Изменение (1 день)
0.39%
Изменение (1 год)
0.00%
Страна
SE
Торговля Lipidor AB (publ) (LIPI)

Категория

Healthcare
Выручка компании Lipidor AB (publ) (LIPI)
Выручка на Dec 2024 TTM: $265.61K
Согласно последним финансовым отчетам Lipidor AB (publ), текущая выручка компании (TTM) составляет $265.61K. В 2023 году компания получила выручку $7.73K больше, чем выручке в 2022 году, которая составила $4.32K. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Lipidor AB (publ) с 2016 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $265.61K 20,825.07%
2024 $1.27K -83.58%
2023 $7.73K 79.16%
2022 $4.32K -99.75%
2021 $1.70M 2,164.63%
2020 $75.02K 872.70%
2019 $7.71K -71.64%
2018 $27.20K -32.61%
2017 $40.36K 30.11%
2016 $31.02K 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B 29,992,925.40%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B 36,868,756.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B 24,240,300.94%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B 29,184,513.78%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B 24,998,542.91%
US